Moreover, tumor cells could employ numerous evasion mechanisms, e.g., defects in their antigen-presentation pathways due to loss of MHC class I heavy chains, β2-microglobulin and/or tapasin expression, to prevent tumor-specific CTL recognition. The gene discussed is HLA-G; the disease is neoplasm.